CBChelsea Balian

Chelsea Balian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chelsea Balian has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Problem-Solving Skills Training for Parents of Children Undergoing Hematopoietic Stem Cell Transplantation: A Mixed Methods Feasibility Study

    by Heather Bemis, Mikela Ritter, Maxwell (Nina) Lee, Paula Murray, Robert Noll, Rebecca Barber, Chelsea Balian, Jessica Ward

    Background: Caregivers of children undergoing hematopoietic stem cell transplantation (HSCT) are at risk for psychological distress. Bright IDEAS® (BI) is an effective and acceptable modification of problem-solving therapy for caregivers of children with new cancer diagnoses, but it has not been tested on caregivers of children undergoing HSCT. This randomized controlled pilot examined the feasibility, acceptability, and preliminary efficacy of BI among caregivers of children undergoing HSCT. Methods: English- and Spanish-speaking caregivers of children aged 2–21 years were recruited within 10 days of their child’s autologous or allogeneic HSCT. Participants were randomized 1:1 to receive six-to-eight individualized BI sessions or usual care. Participants completed self-report measures of psychological distress at enrollment (pre-intervention) and on days 60, 90, and 180 post HSCT. Qualitative interviews were conducted among a subset (N = 7) of intervention completers to assess caregiver perceptions of BI. Results: A total of 107 caregivers were screened for participation; 64 were eligible. Thirty-eight were enrolled (59.4%) and randomized. In the BI group, 14/20 participants (70%) completed six or more sessions. The completion rate for distress measures was at least 78% for both study groups across timepoints. Despite higher baseline scores, caregivers in the BI group reported lower anxiety and depression scores at follow-up timepoints compared to the control group, based on observed trends. Qualitative interviews reflected acceptability of BI. Conclusions: The results support the feasibility and acceptability of BI for caregivers of children undergoing HSCT. A larger efficacy trial of BI in the pediatric HSCT setting is warranted.


  • Electronic Symptom Assessment in Children and Adolescents With Advanced Cancer Undergoing Hematopoietic Stem Cell Transplantation

    by Jessica A. Ward, Chelsea Balian, Elizabeth Gilger, Jennifer L. Raybin, Zhanhai Li, Kathleen E. Montgomery

    Background/Purpose: Effective symptom assessment and management for children with advanced cancer undergoing hematopoietic stem cell transplantation (HSCT) is critical to minimize suffering. The purpose of this subanalysis was to compare feasibility of electronic data collection data and symptom prevalence, frequency, severity, and distress from children with advanced cancer undergoing HSCT with a non-HSCT cohort. Method: An abbreviated Pediatric Quality of Life and Evaluation of Symptoms Technology Memorial Symptom Assessment Scale was electronically administered every 2 weeks to children with advanced cancer. A subanalysis was conducted for the cohort of children who received autologous or allogeneic HSCT. Results: Forty-six participants completed 563 symptom assessments during the study. However, 11 of these 46 children received HSCT and completed 201 symptom assessments. The median age in the HSCT cohort was 12.7 years, 73% were female, and most children had a hematologic (45%) or solid tumor (45%) malignancy. Pain (35%), nausea (30%), sleeping difficulty (29%), and fatigue (22%) were the most commonly reported symptoms in children receiving HSCT. Children in the HSCT cohort had similar total, subscale, and individual symptom scores compared with children who did not receive HSCT. Certain domains of gastrointestinal symptoms (nausea, lack of appetite, and diarrhea) were higher for children receiving HSCT compared with children with advanced cancer not receiving HSCT (p < .05). Conclusion: Elicitation of patient-reported symptom experiences using electronic methods improves nurses’ understanding of the symptom experience for children with advanced cancer undergoing HSCT and may promote timely assessment and treatment of distressing symptoms.


  • NURS-17. PROSPECTIVE SYMPTOM ASSESSMENT IN CHILDREN WITH PROGRESSIVE BRAIN TUMORS

    by Elizabeth Gilger, Molly Hemenway, Jennifer Raybin, Chelsea Balian, Jessica Ward, Kathleen Montgomery

    Children with brain tumors may have unique symptoms at end of life (EOL) compared to other cancers. Most of the pediatric oncology literature regarding symptoms during palliative care or EOL is retrospective. The study purpose was to prospectively describe symptom frequency, severity, and distress level in children/adolescents with advanced cancer using patient self-report and parent proxy. A data subset of subjects with brain tumors was analyzed. The multi-institutional study used a prospective cohort design. Eligibility included 7-18 years, English-speaking, and advanced cancer diagnosis (2-week history of progressive, recurrent, non-responsive disease, or a decision not to pursue curative-focused therapy). A modified Memorial Symptom Assessment Scale (MSAS) version was used. Symptoms were measured electronically biweekly. Disease status and current treatment were recorded. Data was analyzed using descriptive statistics and univariate logistic regression analysis. Out of 47 patient/parent dyads, 15 [WJ1] had a brain tumor. The most frequently reported symptoms by all subjects were pain (n=195/562, 34.70%), lack of energy (n=186/561, 33.16%), and nausea (n=156/560, 27.86%). However, children with brain tumors reported fatigue (94/185=50.81%), irritation (n=43/130, 33.08%), and pain (n=61/185, 32.97%) most frequently. Disease presence (P=0.0006), recent disease progression (P=0.029),[WJ2] receiving cancer therapy (P=0.0045), and high intensity cancer therapy (P=0.0822) were significant factors related to fatigue. Collecting symptom assessment data prospectively in this population is feasible. Although pain was the most frequently reported symptom overall, fatigue and irritability were more prevalent in brain tumor patients. This finding warrants further investigation and potential intervention.


  • A Retrospective Analysis of Bloodstream Infections in Pediatric Allogeneic Stem Cell Transplant Recipients: The Role of Central Venous Catheters and Mucosal Barrier Injury

    by Chelsea Balian, Michelle Garcia, Jessica Ward

    Background: Bloodstream infections (BSIs) are a leading cause of morbidity and mortality in children undergoing hematopoietic stem cell transplant (HSCT). Indwelling central venous catheters (CVCs) increase risk for BSIs, yet mucosal barrier injury–associated laboratory-confirmed bloodstream infection (MBI-LCBI) may also occur due to translocation of pathogenic organisms from the gastrointestinal tract into the bloodstream. The purpose of this study was to determine the association between stool organisms and BSIs in children with CVCs who underwent HSCT. Methods: We performed a retrospective analysis of 78 children who received allogeneic HSCT over 3 years (2012-2014). Surveillance stool cultures were analyzed pre- and post-HSCT to assess correlations between organisms isolated from stool and CVC cultures. Results: Twenty-four of 78 children experienced 31 BSIs. Fifteen (48%) of these isolates were identified in stool within 30 days of the positive blood culture, and 11 (36%) isolates met criteria for MBI-LCBI. Conclusions: Mucosal barrier injury leads to translocation of pathogenic organisms into the bloodstream and accounts for a significant number of BSIs in children undergoing HSCT. Nursing assessment of mucosal changes during HSCT and interventions to preserve intact mucosa are essential to prevent MBI-LCBI.